Cargando…
The Mechanism, Clinical Efficacy, Safety, and Dosage Regimen of Atomoxetine for ADHD Therapy in Children: A Narrative Review
Atomoxetine, a selective norepinephrine (NE) reuptake inhibitor, was approved for attention deficit/hyperactivity disorder (ADHD) treatment in children, adolescents and adults. We searched the database PubMed/MEDLINE (2000 to October 1, 2021). Only publications in English were considered. Atomoxetin...
Autores principales: | Fu, Di, Wu, Dan-Dan, Guo, Hong-Li, Hu, Ya-Hui, Xia, Ying, Ji, Xing, Fang, Wei-Rong, Li, Yun-Man, Xu, Jing, Chen, Feng, Liu, Qian-Qi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863678/ https://www.ncbi.nlm.nih.gov/pubmed/35222104 http://dx.doi.org/10.3389/fpsyt.2021.780921 |
Ejemplares similares
-
A critical appraisal of atomoxetine in the management of ADHD
por: Childress, Ann C
Publicado: (2015) -
Atomoxetine: a novel treatment for child and adult ADHD
por: Ledbetter, Marcialee
Publicado: (2006) -
Atomoxetine for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children with ADHD and dyslexia
por: Sumner, Calvin R, et al.
Publicado: (2009) -
EEG for Diagnosis of Adult ADHD: A Systematic Review With Narrative Analysis
por: Adamou, Marios, et al.
Publicado: (2020) -
Acute neuropharmacological effects of atomoxetine on inhibitory control in ADHD children: A fNIRS study
por: Nagashima, Masako, et al.
Publicado: (2014)